Tag: Diabetes
In brief: CPAP’s adherence assumption, CGM’s benefits, Shaq’s sleep apnea
June 12, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
Study: CGM use lowers A1C in adults with Type 2 diabetes
June 11, 2026HME News Staff
NEW ORLEANS – Adults with Type 2 diabetes who are on of continuous glucose monitoring (CGM) but who are not on insulin saw substantially reduced hyperglycemia, resulting in a large reduction in A1C compared with a routine care control group, according to new researchers presented at the 2026 Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
The study found that CGM was associated with a substantial reduction in hyperglycemia, resulting in a 0.9% greater...
Senseonics, Welldoc partner to develop mobile app for Eversense 365
June 10, 2026HME News Staff
GERMANTOWN & COLUMBIA, Md. – Senseonics and Welldoc have announced a strategic partnership to develop a new custom mobile application for the Eversense 365. The next-generation app will maintain all existing features that patients currently benefit from, alongside new features to enhance user experience and facilitate better integration with popular digital health tools. As part of this, the new and improved Eversense 365 app will facilitate seamless integration with Apple Health and Google...
Abbott secures European clearance for dual glucose/ketone device
May 27, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has secured CE Mark for a dual glucose ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously measure glucose and ketone levels every minute, providing real-time visibility into both glucose levels needed for daily diabetes management and rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency. The company says this marks the first time people with diabetes will be able...
CCS to present latest research on impact of coaching for CGM users
May 20, 2026HME News Staff
ST. PETERSBURG, Fla. – CCS will offer a poster presentation entitled, “Effect of Structured Coaching and Education on Glycemic and Patient-Reported Outcomes Among Adults Initiating CGM: A Randomized Study” at ISPOR 2026 May 17–20 at the Pennsylvania Convention Center in Philadelphia. The poster showcases soon-to-be-published research highlighting the impact of LivingConnected, a DEAP-accredited program delivering coaching and education for adults starting continuous glucose...
Medtronic’s MiniMed board sees shake up
May 19, 2026HME News Staff
NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy...
CGM: Avoid the leaky bucket
May 13, 2026Brett Siegal
Q. I'm adding CGM patients every month, but my overall program is not growing the way I'd expect. What am I missing?
A. Your program might have a leaky bucket.
It's one of the most common and costly problems in CGM resupply. Providers focus heavily on new patient acquisition, which is important, but if patients are quietly dropping off the back end, acquisition alone will not grow your resupply program at the rate you're expecting. You could be adding 50 new patients a month...
Insulet sees momentum, raises outlook
May 7, 2026HME News Staff
ACTON, Mass. – Insulet reported revenue of $761.7 million for the first quarter of 2026, an increase of 33.9% over the prior year. Total Omnipod revenue was $758.4 million, up 36.9%. Of that, U.S. Omnipod revenue was $515.6 million and international Omnipod revenue was $242.9 million.
“We started the year strong, delivering continued growth momentum and robust operating margin expansion in the first quarter,” said Ashley McEvoy, president and CEO. “Our team executed on...
Tandem’s AID cleared for pregnancies complicated by Type 1 diabetes mellitus
April 29, 2026HME News Staff
SAN DIEGO – Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by Type 1 diabetes mellitus. Control-IQ+ powers both insulin delivery systems from Tandem – the t:slim X2 and Tandem Mobi, the first and only commercially available AID systems cleared for use during pregnancy in the United States. “Glycemic goals are tighter during pregnancy,” said...
Senseonics launches Eversense 365 in Sweden, other countries to follow
April 27, 2026HME News Staff
GERMANTOWN, Md. – Senseonics Holdings has launched its Eversense 365 CGM system in Europe, following CE Mark approval in January. The Eversense 365 is now available to the first patients in Sweden, with launches to follow in Germany, Spain, and Italy during the coming weeks.The next-generation Eversense 365 doubles sensor lifespan from the previously available Eversense E3, from six months to a full year, and delivers key improvements such as reducing the frequency of calibrations from once...